AUCPED
LIVE

Serial Number

99489425

Owner

Shanghai Aucta Pharmaceuticals Co., Ltd.

Attorney

Meng Ke

First Use Date

Sep 15, 2025

Filing Date

Nov 11, 2025

Add to watchlist:

No watchlists yet
View on USPTO

AUCPED Trademark

Serial Number: 99489425 • Registration: 8284537

AUCPED is a trademark filed by Shanghai Aucta Pharmaceuticals Co., Ltd. on November 11, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Shanghai Aucta Pharmaceuticals Co., Ltd. (6 trademarks)

No. 10, Lane 100, Banxia Road, Pudong New Area
Shanghai 201318 , CN

Entity Type: 99

Trademark Details

Filing Date

November 11, 2025

Registration Date

June 2, 2026

First Use Anywhere

September 15, 2025

First Use in Commerce

September 15, 2025

Published for Opposition

April 14, 2026

Goods & Services

Ophthalmologic preparations; Allergy medication; Pharmaceutical preparations, namely, appetite suppressants; Bronchodilators; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Anti-diabetic pharmaceuticals; Anti-epileptic pharmaceutical preparations; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical agents affecting metabolism; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Chemical reagents for medical use

Filing History

REGISTERED-PRINCIPAL REGISTER
Jun 2, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 14, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 14, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 8, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 21, 2026 CNSA
ASSIGNED TO EXAMINER
Mar 20, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 11, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 11, 2025 NWOS
NEW APPLICATION ENTERED
Nov 11, 2025 NWAP